Shaker Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
LMFP
PR
AAS
WAM
RFM
NHFG
MFS
LRPA
SGH
EWM
Shaker Investments's XBI Position: Q2 2026 in Review
Shaker Investments increased its State Street SPDR S&P Biotech ETF (XBI) stake by 2.7% in Q2 2026, buying an estimated $140K and bringing the position to 39,501 shares worth $6.25M. The position accounts for 2.25% of the portfolio, ranked #10.
Shaker Investments first reported a position in XBI in Q4 2020 and has held it in 18 quarters since. 260 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Shaker Investments held 39,501 shares of State Street SPDR S&P Biotech ETF worth $6.25M as of Q2 2026.
- Shaker Investments bought 1,037 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $140K.
- State Street SPDR S&P Biotech ETF made up 2.25% of Shaker Investments's portfolio in Q2 2026, its #10 holding.
- Shaker Investments first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 18 quarters since.
- 260 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Shaker Investments's 13F filing for Q2 2026, filed 15 Jul 2026.